Date: 2014-09-19
Type of information: Nomination
Compound:
Company: Molecular Partners (Switzerland)
Therapeutic area:
Type agreement:
Action mechanism:
Disease:
Details: * On September 19, 2014, Molecular Partners AG announced the appointment of Steven H. Holtzman as an independent non-executive member of its board of directors. Mr. Holtzman is currently serving as Executive Vice President, Corporate Development on the Executive
Committee of Biogen Idec. Prior to that, Steven Holtzman was a founder, initially Chief Executive Officer and Chairman of the Board of Infinity Pharmaceuticals, Inc., Chief Business Officer at Millennium Pharmaceuticals, Inc. and a founder and member of the Board of
Directors and Executive Vice President of DNX Corporation.
Steven Holtzman is a board member or trustee of the Biotechnology Industry Organization (BIO), PMV Pharma (a private biotechnology company), the Berklee College of Music, and the Board of Overseers of the Isabella Stewart Gardner Museum. He used to serve as a
presidential appointee to the US National Bioethics Advisory Commission.
Financial terms:
Latest news:
